Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This phase II study investigating the efficacy and safety of a combination of
biaxin,lenalidomide and dexamethasone in subjects with relapsed/refractory MM.